Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1977 Dec;6(6):627-32.
doi: 10.1128/jcm.6.6.627-632.1977.

Anti-complement immunofluorescence test for antibodies to human cytomegalovirus

Comparative Study

Anti-complement immunofluorescence test for antibodies to human cytomegalovirus

J D Kettering et al. J Clin Microbiol. 1977 Dec.

Abstract

An anti-complement immunofluorescence (ACIF) test that detects human cytomegalovirus (CMV) antigen in the nuclei of infected cells was used for assay of CMV antibodies in human sera. Various factors influencing the sensitivity and specificity of the ACIF test system were investigated, and results were applied to the development of a procedure which could be completed in a relatively short length of time and gave reproducible results. Results obtained in the ACIF test were compared with those obtained in complement fixation, indirect hemagglutination, and neutralization tests, and the ACIF test was shown to be suitable for detection of significant antibody titer rises and stationary levels of CMV antibody. Heterotypic antibody responses were not seen with sera from other human herpesvirus infections. The nonspecific cytoplasmic staining that occurs in indirect immunofluorescence tests for CMV did not occur in the ACIF system, and sera that were anti-complementary in complement fixation tests could be examined satisfactorily by ACIF. Thus, the test is a valuable supplemental or back-up procedure for the serodiagnosis of CMV infection.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Tumori. 1976 Nov-Dec;62(6):609-14 - PubMed
    1. Infect Immun. 1977 May;16(2):522-6 - PubMed
    1. Infect Immun. 1976 Nov;14(5):1184-90 - PubMed
    1. Int J Cancer. 1974 Jun 15;13(6):751-4 - PubMed
    1. Scand J Infect Dis. 1972;4(2):109-12 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources